Avandia Probes Lead To ERISA Class Suit Against GSK
GlaxoSmithKline PLC is in hot water again over its diabetes drug Avandia, this time with a putative class of retirement plan participants who say the company and its directors breached fiduciary...To view the full article, register now.
Already a subscriber? Click here to view full article